GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 3676 - 3700 of 4050 in total
Antibody Patient Onset (days) Symptom GlyTouCan ID Arbitrary Fluorescence Units (AFU) ▲
IgM Patient 1 22 moderate
G43534QA
1476
IgG Patient 2 3 mild
G35446HX
1491
IgM Patient 4 12 mild
G09482NW
1495
IgM Patient 2 15 mild
G80587NA
1497
IgA Patient 3 11 mild
G51175PR
1499
IgA Patient 1 22 moderate
G81315DD
1506
IgA Patient 2 15 mild
G21675ZL
1530
IgA Patient 4 12 mild
G71469XA
1530
IgM Patient 2 15 mild
G21675ZL
1532
IgG Patient 2 3 mild
G91537AT
1537
IgM Patient 2 3 mild
G71142DF
1537
IgA Patient 2 3 mild
G49108TO
1571
IgM Patient 4 12 mild
G96557TJ
1572
IgG Patient 2 24 mild
G21675ZL
1600
IgM Patient 1 22 moderate
G71142DF
1605
IgG Patient 2 15 mild
G25559RS
1605
IgM Patient 3 11 mild
G47362BJ
1619
IgG Patient 2 3 mild
G38488WF
1622
IgG Patient 2 3 mild
G25559RS
1635
IgM Patient 3 4 mild
G47362BJ
1637
IgG Patient 2 24 mild
G26295XE
1657
IgM Patient 4 12 mild
G92823JK
1674
IgA Patient 4 12 mild
G76355TG
1683
IgA Patient 3 4 mild
G26295XE
1687
IgG Patient 3 11 mild
G60761LT
1692

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024